This says to me that revenue might be closer than we think. As it is not a solution to RAPs capital requirements at current cash burn vs. incoming revenue.
There's been a long silence since Pfizer began co-developing the covid screening app. Maybe we are on to something.
How has this screening APP not been sold to lifeworks, etc EAPs
RAP Price at posting:
18.5¢ Sentiment: Buy Disclosure: Held